 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
John Bartlett, MD, The Forum on Performance Measures, 187 12th Street, NE, Suite 5, Atlanta, GA 30324, 404-873-6664, jbartlett@avisagroup.com, Mady Chalk, PhD, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockwall II Building, Suite 740, 5515 Security Lane, Rockville, MD 20852, Deborah W Garnick, ScD, Schneider Institute for Health Policy, Heller Graduate School, Brandeis University, 415 South Street, Mailstop 035, Waltham, MA 02454, David Gastfriend, MD, Addiction Research Program, Massachusetts General Hospital, Back Bay, 388 Commonwealth Avenue, Boston, MA 02115, and Constance Weisner, DrPH, MSW, KP Division of Research, Department of Psychiatry, University of California, San Francisco, 3505 Broadway Avenue, 12th floor, Oakland, CA 94611.
Performance measures estimate or monitor the extent to which the actions of a health care practitioner or provider conform to practice guidelines, medical review criteria, or standards of quality. Alcohol and other drug disorders present special challenges in terms of performance measurement, because these illnesses are unique among chronic disorders. In vulnerable individuals, these chemicals can disrupt users' awareness of satiety; result in behavioral dyscontrol, danger and illness; and reinforce patients' tendencies to exacerbate their illnesses. In addition, patient/provider relationships are complicated when addressing substance use disorders. Nonetheless, performance measures are needed to establish clear standards of accountability that, in turn, will lead to efforts to improve the quality of care for people with AOD disorders. The purpose of this session is to present new performance measures for AOD services, and to explore the complex issues involved in developing, calculating, and using performance measures in this area.
Mady Chalk, Ph.D. Measuring initiation of treatment following detoxification from alcohol and/or drugs - 15 minutes
Deborah Garnick, Sc.D., et. al. Establishing the feasibility of performance measures for alcohol and other drugs - 15 minutes
David Gastfriend, M.D., et. al Policy implications for measuring performance of alcohol and other drug services in health plans - 15 minutes
Constance Weisner, Dr.P.H. et. al. Examining the importance of performance measures for substance abuse services for adolescents - 15 minutes
Moderator and Discussant: John Bartlett, M.D. - 30 minutes (including participants' questions)
Learning Objectives:
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.